The role of IL-5 and eosinophil in IBD is unclear, although a recent study conducted in a mouse model reported the influence of IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF) in increasing the eosinophil activation and tissue damage, which were predominantly dependent on IL-23. The gene discussed is CSF2; the disease is inflammatory bowel disease.